Comprehensive adjusted outcome data are needed to assess the impact of immune checkpoint inhibitors in cancer patients with COVID‐19: Results of a systematic review and meta‐analysis-Reference-Cited by-同舟云学术

Comprehensive adjusted outcome data are needed to assess the impact of immune checkpoint inhibitors in cancer patients with COVID‐19: Results of a systematic review and meta‐analysis

Published:2022-04-13 Issue:5 Volume:32 Page:
ISSN:1052-9276
Container-title:Reviews in Medical Virology
language:en
Short-container-title:Reviews in Medical Virology

Author:

Minkove Samuel J.¹,Sun Junfeng¹,Li Yan¹,Cui Xizhong¹,Cooper Diane²,Eichacker Peter Q.¹,Torabi‐Parizi Parizad¹^ORCID

Affiliation:

1. Critical Care Medicine Department Clinical Center, National Institutes of Health Bethesda Maryland USA

2. NIH Library, Clinical Center, National Institutes of Health Bethesda Maryland USA

Funder

National Institutes of Health

Publisher

Wiley

Subject

Infectious Diseases,Virology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/rmv.2352

Reference82 articles.

1. An interactive web-based dashboard to track COVID-19 in real time

2. COVID-19 and cancer registries: learning from the first peak of the SARS-CoV-2 pandemic

3. Cancer history is an independent risk factor for mortality in hospitalized COVID-19 patients: a propensity score-matched analysis

4. Controversies about COVID-19 and anticancer treatment with immune checkpoint inhibitors

5. At the Crossroads: COVID-19 and Immune-Checkpoint Blockade for Cancer

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Previous immune checkpoint inhibitor therapy is associated with decreased COVID-19-related hospitalizations and complications in patients with cancer: Results of a propensity-matched analysis of the OnCovid registry;International Journal of Infectious Diseases;2024-02

2. Anti-PD-L1 therapy altered inflammation but not survival in a lethal murine hepatitis virus-1 pneumonia model;Frontiers in Immunology;2024-01-08

3. Higher body temperatures associated with immunotherapy may affect the activity of therapeutic antibodies;Reviews in Medical Virology;2024-01

4. Programmed Cell Death Protein 1 Axis Inhibition in Viral Infections: Clinical Data and Therapeutic Opportunities;Vaccines;2022-10-07

5. Health influence of SARS-CoV-2 (COVID-19) on cancer: a review;Acta Biochimica et Biophysica Sinica;2022-10-01